COLLAOBRATIVE AGREEMENT (Details Narrative) - Collaborative Agreement [Member] - BioLite Inc., [Member] - Licensing Rights For Drug And Therapeutic Use of Five Products [Member] - USD ($)

9 Months Ended

May 06, 2016

Dec. 29, 2015

Jun. 30, 2016

Total consideration

$ 2,600,000

$ 100,000,000

Upfront payment

$ 3,500,000

Value of shares issued for aquisition

$ 900,000

Number of shares issued for aquisition

562,500

Share price (in dollars per share)

$ 1.60

Description of agreement terms

This Collaborative Agreement shall, once signed by both Parties, remain in effect for fifteen years as of the first commercial sales of the Product in the Territory and automatically renew for five more years unless either party gives the other party six month written notice of termination prior to the expiration date of the term.